Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CYIENT.NS Stock Summary
Top 10 Correlated ETFs
CYIENT.NS
In the News
CYIENT.NS Financial details
Company Rating
Buy
Market Cap
215.45B
Income
6.57B
Revenue
71.19B
Book val./share
397.13
Cash/share
101.36
Dividend
28
Dividend %
1.26%
Employees
12.04K
Optionable
No
Shortable
Yes
Earnings
18 Apr 2024
P/E
36.61
Forward P/E
24.33
PEG
14.34
P/S
3.53
P/B
6.04
P/C
19.7
P/FCF
-
Quick Ratio
1.54
Current Ratio
1.96
Debt / Equity
0.18
LT Debt / Equity
0.09
-
-
EPS (TTM)
59.94
EPS next Y
82.05
EPS next Q
18.86
EPS this Y
-1.51%
EPS next Y
36.89%
EPS next 5Y
36.89%
EPS last 5Y
2.08%
Revenue last 5Y
5.72%
Revenue Q/Q
2.41%
EPS Q/Q
-17.58%
-
-
-
-
SMA20
-3.23%
SMA50
-11.98%
SMA100
20.71%
Inst Own
0.2%
Inst Trans
1%
ROA
9%
ROE
35%
ROC
0.2%
Gross Margin
39%
Oper. Margin
15%
Profit Margin
10%
Payout
-
Shs Outstand
109.75M
Shs Float
73.87M
-
-
-
-
Target Price
-
52W Range
942.0-2458.95
52W High
-18.78%
52W Low
+111.93%
RSI
44
Rel Volume
1.1
Avg Volume
314.55K
Volume
346.82K
Perf Week
0.05%
Perf Month
-5.52%
Perf Quarter
18.67%
Perf Half Y
21.38%
-
-
-
-
Beta
1.171
-
-
Volatility
22.2%, 49.42%
Prev Close
2.75%
Price
1996.35
Change
2.01%
CYIENT.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 408.78 | 402.62 | 375.55 | 412.72 | 553.68 | |
Net income per share | 42.36 | 31.15 | 33.06 | 47.54 | 46.71 | |
Operating cash flow per share | 32.76 | 52.96 | 77.78 | 57.75 | 50.3 | |
Free cash flow per share | 19.38 | 33.42 | 68.82 | 51.86 | 44.17 | |
Cash per share | 82.77 | 126.67 | 158.71 | 118.36 | 122.04 | |
Book value per share | 226.57 | 232.89 | 268.76 | 283.67 | 314.8 | |
Tangible book value per share | 164.52 | 170.76 | 203.12 | 222.74 | 120.06 | |
Share holders equity per share | 226.57 | 232.89 | 268.76 | 283.67 | 314.8 | |
Interest debt per share | 35.34 | 65.38 | 56.42 | 55.77 | 119.67 | |
Market cap | 73.38B | 25.21B | 71.24B | 101.93B | 109.6B | |
Enterprise value | 67.99B | 22.92B | 62.63B | 95.52B | 115.56B | |
P/E ratio | 15.34 | 7.36 | 19.58 | 19.52 | 21.31 | |
Price to sales ratio | 1.59 | 0.57 | 1.72 | 2.25 | 1.8 | |
POCF ratio | 19.83 | 4.33 | 8.32 | 16.06 | 19.79 | |
PFCF ratio | 33.52 | 6.86 | 9.41 | 17.89 | 22.53 | |
P/B Ratio | 2.87 | 0.98 | 2.41 | 3.27 | 3.16 | |
PTB ratio | 2.87 | 0.98 | 2.41 | 3.27 | 3.16 | |
EV to sales | 1.47 | 0.52 | 1.52 | 2.11 | 1.9 | |
Enterprise value over EBITDA | 9.04 | 3.31 | 8.14 | 10.81 | 10.66 | |
EV to operating cash flow | 18.37 | 3.94 | 7.32 | 15.06 | 20.86 | |
EV to free cash flow | 31.06 | 6.24 | 8.27 | 16.76 | 23.76 | |
Earnings yield | 0.07 | 0.14 | 0.05 | 0.05 | 0.05 | |
Free cash flow yield | 0.03 | 0.15 | 0.11 | 0.06 | 0.04 | |
Debt to equity | 0.14 | 0.26 | 0.2 | 0.18 | 0.35 | |
Debt to assets | 0.09 | 0.16 | 0.13 | 0.12 | 0.19 | |
Net debt to EBITDA | -0.72 | -0.33 | -1.12 | -0.72 | 0.55 | |
Current ratio | 2.61 | 2.21 | 2.57 | 2.3 | 1.58 | |
Interest coverage | 16.93 | 8.26 | 9.4 | 16.05 | 7.52 | |
Income quality | 0.78 | 1.71 | 2.35 | 1.21 | 1.08 | |
Dividend Yield | 0.02 | 0.1 | 0 | 0.03 | 0.02 | |
Payout ratio | 0.23 | 0.77 | 0 | 0.57 | 0.51 | |
Sales general and administrative to revenue | 0.02 | 0.04 | 0.04 | 0.04 | 0.05 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.16 | 0.16 | 0.14 | 0.33 | |
Capex to operating cash flow | -0.41 | -0.37 | -0.12 | -0.1 | -0.12 | |
Capex to revenue | -0.03 | -0.05 | -0.02 | -0.01 | -0.01 | |
Capex to depreciation | -1.36 | -1.14 | -0.51 | -0.34 | -0.26 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Graham number | 464.71 | 403.99 | 447.14 | 550.84 | 575.2 | |
ROIC | 0.14 | 0.08 | 0.08 | 0.12 | 0.11 | |
Return on tangible assets | 0.15 | 0.1 | 0.1 | 0.13 | 0.12 | |
Graham Net | 70.12 | 39 | 101.94 | 56.09 | -61.52 | |
Working capital | 15.96B | 13.52B | 17.43B | 16.35B | 11.68B | |
Tangible asset value | 18.58B | 18.78B | 22.35B | 24.47B | 13.22B | |
Net current asset value | 12.54B | 8.43B | 13.13B | 12.23B | 1.07B | |
Invested capital | 0.14 | 0.26 | 0.2 | 0.18 | 0.35 | |
Average receivables | 12.96B | 10.95B | 9.2B | 11.23B | 11.3B | |
Average payables | 3.76B | 3.72B | 4.13B | 4.9B | 6.2B | |
Average inventory | 1.57B | 2.05B | 1.93B | 2.19B | 3.57B | |
Days sales outstanding | 115.64 | 59.87 | 98.31 | 91.26 | 67.47 | |
Days payables outstanding | 45.61 | 47.32 | 66.23 | 72.36 | 70.03 | |
Days of inventory on hand | 22.52 | 28.77 | 23.18 | 38.39 | 42.73 | |
Receivables turnover | 3.16 | 6.1 | 3.71 | 4 | 5.41 | |
Payables turnover | 8 | 7.71 | 5.51 | 5.04 | 5.21 | |
Inventory turnover | 16.2 | 12.69 | 15.75 | 9.51 | 8.54 | |
ROE | 0.19 | 0.13 | 0.12 | 0.17 | 0.15 | |
Capex per share | -13.39 | -19.54 | -8.95 | -5.89 | -6.13 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 146.99 | 165.83 | 152.5 | 160.69 | 164.45 | |
Net income per share | 14.17 | 14.77 | 15.2 | 16.11 | 13.29 | |
Operating cash flow per share | 12.7 | 13.14 | 12.23 | 11.89 | 11.94 | |
Free cash flow per share | 12.7 | 13.14 | 12.23 | 11.89 | 11.94 | |
Cash per share | 64.07 | 121.59 | 113.81 | 156.04 | 101.36 | |
Book value per share | 295.36 | 313.66 | 349.29 | 364.8 | 397.13 | |
Tangible book value per share | 150.14 | 119.63 | 200.3 | 201.99 | 245.13 | |
Share holders equity per share | 295.36 | 313.66 | 349.29 | 364.8 | 397.13 | |
Interest debt per share | 115.71 | 112.56 | 99.02 | 96.33 | 72.82 | |
Market cap | 89.29B | 110B | 165.97B | 187.52B | 254.84B | |
Enterprise value | 95.6B | 115.96B | 165.34B | 192.81B | 254.32B | |
P/E ratio | 14.31 | 16.85 | 24.68 | 26.29 | 43.28 | |
Price to sales ratio | 5.52 | 6 | 9.84 | 10.54 | 13.99 | |
POCF ratio | 63.87 | 75.76 | 122.76 | 142.49 | 192.77 | |
PFCF ratio | 63.87 | 75.76 | 122.76 | 142.49 | 192.77 | |
P/B Ratio | 2.75 | 3.17 | 4.3 | 4.64 | 5.79 | |
PTB ratio | 2.75 | 3.17 | 4.3 | 4.64 | 5.79 | |
EV to sales | 5.91 | 6.33 | 9.8 | 10.84 | 13.96 | |
Enterprise value over EBITDA | 30.76 | 35.96 | 50.75 | 56.83 | 73.74 | |
EV to operating cash flow | 68.38 | 79.86 | 122.29 | 146.51 | 192.37 | |
EV to free cash flow | 68.38 | 79.86 | 122.29 | 146.51 | 192.37 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0.38 | 0.35 | 0.28 | 0.26 | 0.18 | |
Debt to assets | 0.2 | 0.19 | 0.15 | 0.15 | 0.11 | |
Net debt to EBITDA | 2.03 | 1.85 | -0.19 | 1.56 | -0.15 | |
Current ratio | 1.31 | 1.58 | 1.63 | 1.96 | 1.94 | |
Interest coverage | 9.16 | 9.54 | 8.92 | 10.13 | 9.68 | |
Income quality | 0.9 | 0.89 | 0.8 | 0.74 | 0.9 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.19 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | 0.26 | 0.33 | 0.23 | 0.3 | 0.23 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 306.87 | 322.82 | 345.63 | 363.64 | 344.6 | |
ROIC | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Return on tangible assets | 0.03 | 0.04 | 0.03 | 0.04 | 0.03 | |
Graham Net | -114.53 | -61.3 | -74.52 | 10.82 | -37.72 | |
Working capital | 6.73B | 11.68B | 14.14B | 18.43B | 18.02B | |
Tangible asset value | 16.53B | 13.22B | 22.15B | 22.36B | 27.15B | |
Net current asset value | -906M | 1.07B | 5.22B | 9.97B | 9.3B | |
Invested capital | 0.38 | 0.35 | 0.28 | 0.26 | 0.18 | |
Average receivables | 9.86B | 10.77B | 11.27B | 11.75B | 12.81B | |
Average payables | 6.76B | 7.04B | 6.95B | 6.67B | 6.5B | |
Average inventory | 4.3B | 4.44B | 4.45B | 4.61B | 4.8B | |
Days sales outstanding | 57.07 | 55.35 | 60.14 | 61.85 | 66.18 | |
Days payables outstanding | 62.3 | 59.94 | 58.25 | 53.8 | 50.03 | |
Days of inventory on hand | 40.55 | 36.58 | 39.12 | 38.31 | 38.23 | |
Receivables turnover | 1.58 | 1.63 | 1.5 | 1.46 | 1.36 | |
Payables turnover | 1.44 | 1.5 | 1.55 | 1.67 | 1.8 | |
Inventory turnover | 2.22 | 2.46 | 2.3 | 2.35 | 2.35 | |
ROE | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CYIENT.NS Frequently Asked Questions
What is Cyient Limited stock symbol ?
Cyient Limited is a IN stock and trading under the symbol CYIENT.NS
What is Cyient Limited stock quote today ?
Cyient Limited stock price is $1996.35 today.
Is Cyient Limited stock public?
Yes, Cyient Limited is a publicly traded company.